Supplemental material
Modern Rheumatology
Volume 29, 2019 - Issue 5
Open access
1,701
Views
4
CrossRef citations to date
0
Altmetric
Original Article
Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance
Hisashi YamanakaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
, Tomohiro HirosePfizer Japan Inc., Tokyo, Japan; Correspondence[email protected]
View further author information
, View further author information
Yutaka EndoPfizer Japan Inc., Tokyo, Japan; View further author information
, Noriko SugiyamaPfizer Japan Inc., Tokyo, Japan; View further author information
, Yuri FukumaPfizer Japan Inc., Tokyo, Japan; View further author information
, Yosuke MorishimaPfizer Japan Inc., Tokyo, Japan; View further author information
, Naonobu SugiyamaPfizer Japan Inc., Tokyo, Japan; View further author information
, Noritoshi YoshiiPfizer Japan Inc., Tokyo, Japan; View further author information
, Nobuyuki MiyasakaDepartment of Rheumatology, Tokyo Medical & Dental University, Tokyo, Japan; View further author information
& Takao KoikeHokkaido Medical Center for Rheumatic Diseases, Sapporo, JapanView further author information
show all
Pages 737-746
|
Received 17 May 2018, Accepted 23 Jul 2018, Published online: 20 Sep 2018
Related Research Data
Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010
Source:
Informa UK Limited
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial
Source:
Informa UK Limited
Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)
Source:
Informa UK Limited
Wie unterstützen Registerdaten die klinische Entscheidungsfindung?
Source:
Springer Nature
Guidelines for the proper use of etanercept in Japan
Source:
Informa UK Limited
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
Source:
Oxford University Press (OUP)
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial
Source:
Informa UK Limited
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
Source:
Springer Nature
Comparison of Treatment Strategies in Early Rheumatoid Arthritis
Source:
American College of Physicians
Pharmacokinetics, efficacy and safety profiles of etanercept monotherapy in Japanese patients with rheumatoid arthritis: review of seven clinical trials
Source:
Informa UK Limited
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
Source:
BMJ
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
Source:
Springer Nature
Predictors of infection in rheumatoid arthritis
Source:
Wiley
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Source:
Informa UK Limited
Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance
Source:
Taylor & Francis
ACR RA TREATMENT RECOMMENDATIONS
Source:
Wiley
The Japanese experience with biologic therapies for rheumatoid arthritis
Source:
Springer Science and Business Media LLC
ACR RA TREATMENT RECOMMENDATIONS
Source:
Wiley
Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation: the CHANGE study
Source:
Informa UK Limited
Validity and reliability of a scale to assess fatigue
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.